ArticleJournal of medicinal chemistry2006

Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists.

Zhan-Guo Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.